Gts Securities LLC Guardant Health, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$22.3 - $36.29 $176,170 - $286,691	7,900 Added 26.33%	37,900 $869,000
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $17,677 - $35,024	-1,100 Reduced 3.54%	30,000 $866,000
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $89,076 - $139,932	5,200 Added 20.08%	31,100 $641,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $254,643 - $348,100	11,800 Added 83.69%	25,900 $700,000
Q3 2023 Nov 15, 2023	BUY	$25.8 - $39.97 $363,780 - $563,577	14,100 New	14,100 $417,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.